FIELD: medicine.
SUBSTANCE: invention relates to the use of isovaleryl-spiramycin I or III or their pharmaceutically acceptable salts in the manufacture of a drug for the treatment of a tumor, while the tumor includes mammary gland cancer, liver cancer, lung cancer, kidney cancer, brain tumor, cervical cancer, prostate cancer, lymphoma, pancreatic cancer, esophageal cancer, stomach cancer, colon cancer, thyroid cancer, bladder cancer, leukemia or skin cancer, while the dose of isovaleryl-spiramycin I or III in the drug is in the range from 5 to 1500 mg.
EFFECT: obtaining a drug for the treatment of tumors.
7 cl, 52 tbl, 2 ex
Title |
Year |
Author |
Number |
THE USE OF CARRIMYCIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PRODUCTION OF MEDICINES FOR TREATMENT AND / OR TUMOR PREVENTION |
2018 |
- Dzhiang, Enkhong
- Ksia, Mingyu
- Dzhiang, Ksyunlej
- Dzhiang, Ksyundong
|
RU2746047C1 |
RAPAMYCIN TARGET INHIBITOR IN MAMMALIAN CELLS, PHARMACEUTICAL COMPOSITION AND USE THEREOF |
2019 |
- Ksia, Mingyu
- Zhao, Ksiaofeng
- Dzhiang, Ksyunlej
- Dzhiang, Ksyundong
|
RU2768583C2 |
USE OF CARRIMYCIN OR ITS ACTIVE INGREDIENTS |
2019 |
- Ksia, Mingyu
- Zhao, Ksiaofeng
- Dzhiang, Ksyunlej
- Dzhiang, Ksyundong
|
RU2771046C2 |
LEVOROTATORY ISOVALERYLSPIRAMYCIN 1, II, III, PREPARATIONS, METHOD FOR PREPARATION AND USE |
2011 |
|
RU2593498C2 |
LEVOISOVALERIL SPIRAMYCIN II, PREPARATIONS, METHOD OF PREPARATION AND USE |
2011 |
|
RU2647236C1 |
NEUTRAL LIPIDS FROM JOB'S TEARS GRAINS NLKY, METHOD OF THEIR PREPARING, COMPOSITION BASED ON THEREOF, NEUTRAL LIPIDS FOR USE AS A DRUG |
1993 |
|
RU2123853C1 |
ANTITUMOUR DRUG CONTAINING ANTITUMOUR PLATINUM COMPLEX, AND ANTITUMOUR EFFECT ENHANCER |
2015 |
|
RU2678103C2 |
NOVEL DIMERS OF CYTIDINE DERIVATIVES AND USE THEREOF |
2015 |
- Yan Daria
- Van Khajdun
- Van Khojtszyuan
- Le Syon Tern
|
RU2687252C2 |
DOSAGE FORM LEVOCARRIMYCIN, METHOD FOR PRODUCTION AND USE THEREOF |
2011 |
|
RU2593499C2 |
CONTROL POINT INHIBITOR AND WHOLE MYCOBACTERIAL CELLS FOR USE IN CANCER THERAPY |
2016 |
- Akle Charles
- Brunet Laura Rosa
|
RU2733033C2 |